Essential Guide to Neurodegenerative Disorders: Mechanistic, Diagnostic and Therapeutic Advances
Editat de Wael Mohameden Limba Engleză Paperback – 28 noi 2024
- Reviews big data and neurodegeneration disorders, including gene mapping
- Examines the structural basis of protein assembly into amyloid filaments in neurodegenerative disease
- Covers the progress and challenges of pharmacotherapy of neurodegenerative disorders
Preț: 1170.47 lei
Preț vechi: 1286.23 lei
-9% Nou
Puncte Express: 1756
Preț estimativ în valută:
224.00€ • 232.68$ • 186.07£
224.00€ • 232.68$ • 186.07£
Carte tipărită la comandă
Livrare economică 27 ianuarie-10 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780443157028
ISBN-10: 0443157022
Pagini: 700
Dimensiuni: 191 x 235 mm
Greutate: 0.45 kg
Editura: ELSEVIER SCIENCE
ISBN-10: 0443157022
Pagini: 700
Dimensiuni: 191 x 235 mm
Greutate: 0.45 kg
Editura: ELSEVIER SCIENCE
Cuprins
Part-I: Mechanism of cell death in neurodegeneration
1. Pathways in AD
2. Shared signalling pathways in Alzheimer’s and metabolic disease
3. Abeta pathology in AD and its potential to seed and propagate
4. Single-cell approaches to identify shared and distinct signatures across neurodegenerative diseases
5. Modelling of neurodegenerative disease using brain organoids
6. The structural basis of protein assembly into amyloid filaments in neurodegenerative disease-Benjamin
7. Blood brain barrier in neurodegenerative disorders
8. Protein misfolding in neurodegeneration
9. Neuroinflammation and neurodegeneration
10. Gut-Brain Axis in neurodegeneration
11. Modelling Neural Circuits in Parkinson’s Disease
12. Neuropathology of Parkinsonism in Alzheimer’s Disease
13. Huntington Disease updates
14. Neuroinflammation in neurodegeneration
Part-II: Gene and gene products in neurodegeneration
15. Big data and neurodegeneration disorders
16. Genomics and PD
17. RNA Binding Proteins and the Genesis of Neurodegenerative Diseases-Ahmed Moustafa, Egypt
18. Molecular Genetics of Huntington’s Disease
19. neuronopathic LSDs: opportunities and challenges
20. Nutrigenomics and PD
21. Genes and MS: updates
22. Genetic mapping and big data in ALS
Part-III: Present and future diagnostic approaches of neurodegenerative disorders
23. Biomarkers in AD
24. Biomarkers of PD
25. HMGB complex in PD diagnosis
26. Psychological assessment of PD patients
Part-IV: Present and future therapeutics of neurodegenerative disorders
27. Pharmacotherapy of neurodegenerative disorders: challenges and hopes
28. Advanced Drug Delivery Nanosystems: Perspectives and Regulatory Issues
29. Towards the Development of a Device to Improve the Gait of Patients Suffering from Parkinson’s Disease
30. Developing Antisense Therapies for Neurodegenerative Diseases
31. Advances in Gene Therapies for the CNS
32. Nutrition and PD
33. Stem cell therapy in NDG disorders
1. Pathways in AD
2. Shared signalling pathways in Alzheimer’s and metabolic disease
3. Abeta pathology in AD and its potential to seed and propagate
4. Single-cell approaches to identify shared and distinct signatures across neurodegenerative diseases
5. Modelling of neurodegenerative disease using brain organoids
6. The structural basis of protein assembly into amyloid filaments in neurodegenerative disease-Benjamin
7. Blood brain barrier in neurodegenerative disorders
8. Protein misfolding in neurodegeneration
9. Neuroinflammation and neurodegeneration
10. Gut-Brain Axis in neurodegeneration
11. Modelling Neural Circuits in Parkinson’s Disease
12. Neuropathology of Parkinsonism in Alzheimer’s Disease
13. Huntington Disease updates
14. Neuroinflammation in neurodegeneration
Part-II: Gene and gene products in neurodegeneration
15. Big data and neurodegeneration disorders
16. Genomics and PD
17. RNA Binding Proteins and the Genesis of Neurodegenerative Diseases-Ahmed Moustafa, Egypt
18. Molecular Genetics of Huntington’s Disease
19. neuronopathic LSDs: opportunities and challenges
20. Nutrigenomics and PD
21. Genes and MS: updates
22. Genetic mapping and big data in ALS
Part-III: Present and future diagnostic approaches of neurodegenerative disorders
23. Biomarkers in AD
24. Biomarkers of PD
25. HMGB complex in PD diagnosis
26. Psychological assessment of PD patients
Part-IV: Present and future therapeutics of neurodegenerative disorders
27. Pharmacotherapy of neurodegenerative disorders: challenges and hopes
28. Advanced Drug Delivery Nanosystems: Perspectives and Regulatory Issues
29. Towards the Development of a Device to Improve the Gait of Patients Suffering from Parkinson’s Disease
30. Developing Antisense Therapies for Neurodegenerative Diseases
31. Advances in Gene Therapies for the CNS
32. Nutrition and PD
33. Stem cell therapy in NDG disorders